At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14 enrolled
Drug / intervention
Standard Carb Diet +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes
In Brief
A clinical study evaluating Standard Carb Diet and Low Carb Diet for Diabetes Mellitus, Type 1. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The investigators will test the hypothesis that reducing insulin doses using a low carbohydrate diet (LCD) will be associated with with improved insulin sensitivity (Aim 1) and blood vessel health (Aim 2).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartNov 2021
Primary CompletionJun 2024
TodayJul 2026
First PostedOct 8, 2019
Enrollment StartNov 24, 2021
Primary CompletionJun 21, 2024
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 6.7 years ago
Interventions
Standard Carb Dietother
Approximately 50% of caloric intake will come from carbohydrate consumption.
Low Carb Dietother
Approximately 25% of caloric intake will come from carbohydrate consumption.